Arctic Bioscience – Mandatory notification of trade by CEO Christer L. Valderhaug

Christer L. Valderhaug, CEO of Arctic Bioscience, has today bought 10,000 shares in Arctic Bioscience at an average price of NOK 15.4925 per share. Following the transaction, Christer L. Valderhaug holds 10,000 shares and 250,000 share options in Arctic Bioscience.

Please refer to the attached notification of trading for further details. 

This information is subject to the disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19 number 3 and the Norwegian Securities Trading Act § 5-12.